TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
23,674
24,999
27,119
28,014
25,156
Cost of Revenue
8,958
9,456
13,114
12,318
12,557
Gross Profit
14,716
15,543
14,005
15,696
12,599
Operating Expenses
Research Development
3,430
3,587
4,691
5,152
6,951
Selling General and Administrative
9,300
9,494
21,102
25,454
34,284
Total Operating Expenses
12,730
13,081
25,793
31,672
42,736
Operating Income or Loss
1,986
2,462
-11,788
-15,976
-30,137
Interest Expense
5,210
4,709
-
4,003
-
Total Other Income/Expenses Net
4
-4,713
-4,313
-3,944
-3,092
Income Before Tax
-3,220
-2,251
-16,101
-19,920
-33,229
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-3,220
-2,251
-16,101
-19,920
-33,229
Net Income
-3,220
-2,251
-16,101
-19,920
-33,229
Net Income available to common shareholders
-3,220
-2,251
-16,101
-19,920
-33,229
Reported EPS
Basic
-
-0.21
-2.78
-4.29
-9.90
Diluted
-
-0.21
-2.78
-4.29
-9.90
Weighted average shares outstanding
Basic
-
10,616
5,790
4,648
3,370
Diluted
-
10,616
5,790
4,648
3,373
EBITDA
-
2,462
-11,788
-14,910
-28,636